Aligos Therapeutics Inc (NASDAQ:ALGS)
| 1.11 Delayed Data As of Mar 27 |  -0.02 / -1.77%Today’s Change | 0.84 Today|||52-Week Range 2.41 | +16.49% Year-to-Date |
Latest ALGS News | Press Releases
No recent news for Aligos Therapeutics Inc.
Today’s Trading
| Previous close | 1.13 |
| Today’s open | 1.08 |
| Day’s range | 1.08 - 1.11 |
| Volume | 572 |
| Average volume (3 months) | 314,117 |
| Market cap | $47.7M |
Data as of 3:42pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +30.13% |
| Earnings growth (this year) | +29.63% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +219.04% |
| P/E ratio | NM |
| Price/Sales | 2.93 |
| Price/Book | 0.45 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 8, 2023 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $13.9M |
| Annual profit (last year) | -$96.0M |
| Net profit margin | -690.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
